Newsfeeds Archive - Spark Newswire

1 minute read

Syneos Health Signs Agreement With Aotearoa Clinical Trials, Further Expanding Catalyst Site Program In New Zealand

August 10, 10:53 AM

Syneos Health® (NASDAQ:SYNH) a leading fully integrated biopharmaceutical solutions organization, today announced that it has signed an agreement with Aotearoa Clinical Trials, expanding the Company’s

SYNH

1 minute read

Syneos Health Stockholders Approve Agreement With Private Investment Consortium

By Happy Mohamed

August 2, 8:48 AM

Syneos Health, Inc. (NASDAQ:SYNH) ("Syneos Health" or the "Company"), a leading fully integrated biopharmaceutical solutions organization, today announced that the Company's stockholders approved

SYNH

3 minute read

Click Therapeutics Launches Additional Randomized Clinical Study In Migraine, Conducted In Partnership With Syneos Health

By Happy Mohamed

August 2, 8:17 AM

● The study marks Click's second active randomized clinical trial testing digital interventions in migraine patients. ● The ReMMiD-C trial will evaluate the efficacy and safety of investigational digital

SYNH

1 minute read

Analyst Ratings

8 Analysts Have This to Say About Syneos Health

By Benzinga Insights

May 16, 5:02 PM

Analysts have provided the following ratings for Syneos Health (NASDAQ:SYNH) within the last quarter: Bullish Somewhat Bullish Indifferent…

SYNH

1 minute read

Syneos Health Target Price Raised Amid $7.1B Acquisition News: Analyst Provides Insight

By Nabaparna Bhattacharya

May 16, 2:34 PM

Mizuho analyst Ann Hynes reiterated a Neutral rating on the shares of Syneos Health, Inc. (NASDAQ:SYNH), raising the price target to $43…

SYNH

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For May 11, 2023

By Benzinga Insights

May 11, 11:00 AM

Upgrades According to Evercore ISI Group, the prior rating for Phathom Pharmaceuticals Inc (NASDAQ:PHAT) was changed from In-Line…

19 minute read

Earnings

Earnings Scheduled For May 10, 2023

By Benzinga Insights

May 10, 9:12 AM

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earnings at $0.42 per share on revenue of $851.81 million.

AADI

1 minute read

Syneos To Be Acquired By Private Investment Consortium For $7.1B, Q1 Earnings Beat Expectations

By Nabaparna Bhattacharya

May 10, 9:01 AM

Syneos Health Inc (NASDAQ:SYNH) reported the first quarter of FY23 revenues of $1.357 billion, beating the analyst consensus of $1.28…

SYNH

1 minute read

Earnings

Syneos Health: Q1 Earnings Insights

By Benzinga Insights

May 10, 7:15 AM

Syneos Health (NASDAQ:SYNH) reported its Q1 earnings results on Wednesday, May 10, 2023 at 07:00 AM. Here’s what…

SYNH

1 minute read

Syneos Health Close To Being Acquired For $7B – Elliott, Patient Square and Veritas Investment Consortium Lead Deal

By Vandana Singh

May 10, 6:13 AM

A group of investors, including Elliott Investment Management, Patient Square Capital, and Veritas Capital, is close to acquiring Syneos Health Inc (NASDAQ: SYNH) for more than $7 billion, including debt.

SYNH